FOI release

Criminal Enforcement

Case reference FOI2026/00783

Received 18 July 2026

Published 17 August 2026

Request

Thank you for your response. I have clarified my request and restated it for you below: 1) How many of the following types of peptide were seized by the MHRA during in 2024 and 2025? - Retatrutide - BPC-157 - GLP-1 - NAD+ - CJC 1295 -Ipamorelin 2) How many of the following peptide products were seized by the MHRA in the first 5 months of 2026? - Retatrutide - BPC-157 - GLP-1 - NAD+ - CJC 1295 -Ipamorelin 3) How many counterfeit peptide products were seized by the MHRA in the following periods? - the year 2024 - the year 2025 - the first five months of 2026 Please let me know if you require any further clarification. Thanks,

Response

See attached

Documents

• FOI2026_00783 (redacted).pdf (640.9 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.